1. Home
  2. GKOS vs NEU Comparison

GKOS vs NEU Comparison

Compare GKOS & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • NEU
  • Stock Information
  • Founded
  • GKOS 1998
  • NEU 1887
  • Country
  • GKOS United States
  • NEU United States
  • Employees
  • GKOS N/A
  • NEU N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • NEU Major Chemicals
  • Sector
  • GKOS Health Care
  • NEU Industrials
  • Exchange
  • GKOS Nasdaq
  • NEU Nasdaq
  • Market Cap
  • GKOS 5.1B
  • NEU 5.4B
  • IPO Year
  • GKOS 2015
  • NEU N/A
  • Fundamental
  • Price
  • GKOS $94.31
  • NEU $644.26
  • Analyst Decision
  • GKOS Strong Buy
  • NEU
  • Analyst Count
  • GKOS 13
  • NEU 0
  • Target Price
  • GKOS $135.15
  • NEU N/A
  • AVG Volume (30 Days)
  • GKOS 914.5K
  • NEU 36.6K
  • Earning Date
  • GKOS 04-30-2025
  • NEU 07-28-2025
  • Dividend Yield
  • GKOS N/A
  • NEU 1.71%
  • EPS Growth
  • GKOS N/A
  • NEU 20.83
  • EPS
  • GKOS N/A
  • NEU 50.24
  • Revenue
  • GKOS $404,523,000.00
  • NEU $2,790,768,000.00
  • Revenue This Year
  • GKOS $27.89
  • NEU N/A
  • Revenue Next Year
  • GKOS $27.57
  • NEU N/A
  • P/E Ratio
  • GKOS N/A
  • NEU $12.82
  • Revenue Growth
  • GKOS 23.92
  • NEU 3.65
  • 52 Week Low
  • GKOS $77.10
  • NEU $480.00
  • 52 Week High
  • GKOS $163.71
  • NEU $653.71
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 50.08
  • NEU 62.29
  • Support Level
  • GKOS $93.52
  • NEU $630.79
  • Resistance Level
  • GKOS $101.57
  • NEU $646.44
  • Average True Range (ATR)
  • GKOS 3.33
  • NEU 8.79
  • MACD
  • GKOS 0.40
  • NEU -3.29
  • Stochastic Oscillator
  • GKOS 42.24
  • NEU 61.08

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.

Share on Social Networks: